However, we have noted that a prognostic model containing eight genes, including IGF2BP3, for pediatric brain tumors has already been developed recently in a randomized controlled trial, which dramatically enhances the identification of those patients with a poorer prognosis by such gene signature (75). The gene discussed is IGF2BP3; the disease is brain neoplasm.